International Lung Cancer Summit (@lungsummit) 's Twitter Profile
International Lung Cancer Summit

@lungsummit

An interactive conference for thoracic experts to discuss recent advances in the treatment of #LungCancer. Bridging the gap in thoracic oncology together.

ID: 1088112289310523398

linkhttp://www.lungcancersummit.org calendar_today23-01-2019 16:32:40

2,2K Tweet

2,2K Followers

1,1K Following

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Check out the agenda for the upcoming #ILCS24! Join and connect with experts from across the globe, live in Lausanne or online, to discuss the latest advances in #LungCancer treatment and care. Let's bridge the gap in thoracic #oncology together 🌎 Register now ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

You can join us at the #ILCS24 onsite in the beautiful city of Lausanne or virtually online! If you're joining us in person, you can find us at the CHUV / Centre hospitalier universitaire vaudois on October 4th, 2024, from 10AM CET. We look forward to seeing you there 👋

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Ready for another insightful #ILCS? 🫁🔬 Last year's summit set the bar high, and this year we're bringing together world-renowned experts in thoracic oncology once again. Mark your calendars and be part of the conversation! 🗓️ 4th Oct 2024, 10AM CET Explore and register ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Globally, #LungCancer remains the leading cause of cancer-related deaths, with an estimated 1.8 million deaths in 2020 alone. Let's continue our efforts in early detection, innovative treatments, and patient support to fight this devastating disease! #WorldLungCancerDay 🌎🫁

Globally, #LungCancer remains the leading cause of cancer-related deaths, with an estimated 1.8 million deaths in 2020 alone.

Let's continue our efforts in early detection, innovative treatments, and patient support to fight this devastating disease!

#WorldLungCancerDay 🌎🫁
OncoViews (@oncoviews) 's Twitter Profile Photo

With #LungCancer causing 1.8 million deaths globally each year, innovations in immunotherapy and targeted therapies are offering new and improved outcomes. Explore the latest advancements shaping the field of lung cancer treatment on this #WorldLungCancerDay 🌎🫁

Martin Reck (@martinreck2) 's Twitter Profile Photo

Just out! Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer - Clinical Lung Cancer clinical-lung-cancer.com/article/S1525-… #lcsm

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Add the upcoming #ILCS24 to your calendar 🗓️ ⏰ 4th October, from 10AM CET 📍 Live in Lausanne or online Connect with fellow professionals, explore the latest in #LungCancer treatment, and drive progress in care. Register now and be part of the conversation! ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Join Jarushka Naidoo, live in the beautiful city of Lausanne or online, to explore the role of #ADCs in lung cancer treatment at the upcoming #ILCS24! 🗓️ 4th October from 10AM CET Secure your seat and get involved in the discussion with leading experts ⬇️

OncoViews (@oncoviews) 's Twitter Profile Photo

How much tissue do we need for pathological testing for early #LungCancer? 🫁 Hear insights from Lukas Bubendorf, plus much more on tissue acquisition, thoracic surgery, and targeted therapies with Isabelle Opitz, Carolin Steinack, Brendon Stiles and Martin Reck ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Last year’s summit was praised by attendees for its in-depth sessions and valuable networking opportunities. This year, we aim to further elevate the conversation and collaboration in the fight against lung cancer. Join us and contribute to the future of lung cancer care ⬇️

OncoViews (@oncoviews) 's Twitter Profile Photo

The FDA Oncology has recently approved new treatments for #NSCLC including durvalumab with chemotherapy as well as lazertinib in combination with amivantamab-vmjw 🫁 Read more about the approvals ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

What is the current therapeutic landscape for #LungCancer with KRAS, HER2, and C-MET alterations? Explore the topic with Biagio Ricciuti, MD PhD at the upcoming #ILCS24, live in Lausanne or virtually! 🗓️ 4th Oct 2024, from 10AM CET Register and get involved in the discussion ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

Should we take every opportunity to cease immunotherapy for advanced #NSCLC to balance efficacy, toxicity and patient-centered care? Join Giannis Mountzios to explore this question at the #ILCS24, and share your insights! ⏰ 4th Oct, from 10AM CET Register your seat now ⬇️

OncoViews (@oncoviews) 's Twitter Profile Photo

How do we assess #HER2 in immunohistochemistry for lung and lower gastrointestinal cancers? An important question for indications which don't yet have clear guidelines. Explore the question plus much more with Ilaria Colombo, Florian Lordick, and Hochmair Maximilian ⬇️

International Lung Cancer Summit (@lungsummit) 's Twitter Profile Photo

🚨 The #ILCS24 is just ONE MONTH away! Connect with global experts, live in Lausanne or online, to explore the latest discoveries and therapeutic advances in thoracic oncology, alongside Solange Peters and Alfredo Addeo MD as your hosts! Have you secured your spot? Register now ⬇️